Nonresident Prescription Drug Manufacturer-Virtual

A nonresident prescription drug manufacturer – virtual permit is required for any person, located outside of Florida, that is a manufacturer of a prescription drug and that engages in the distribution of such prescription drug into Florida, but does not engage in the physical possession of any prescription drug. A person engaging in activity for which a nonresident prescription drug manufacturer – virtual permit is required, must file an application on form number DBPR-DDC-236.

Requirements:

What is a “manufacturer”? For purposes of qualifying for this permit, a “manufacturer” of a prescription drug does or is one or more of the following:

“Manufacture” means the preparation, deriving, compounding, propagation, processing, producing, or fabrication of any drug, device, or cosmetic.

A person who prepares, derives, manufactures, or produces a drug, device, or cosmetic;

The holder or holders of a New Drug Application (NDA), an Abbreviated New Drug Application (ANDA), a Biologics License Application (BLA), or a New Animal Drug Application (NADA), provided such application has become effective or is otherwise approved consistent with s. 499.023;

A private label distributor for whom the private label distributor’s prescription drugs are originally manufactured and labeled for the distributor and have not been repackaged;

A person registered under the federal act as a manufacturer of a prescription drug, who is described in paragraph (a), paragraph (b), or paragraph (c), who has entered into a written agreement with another prescription drug manufacturer that authorizes either manufacturer to distribute the prescription drug identified in the agreement as the manufacturer of that drug consistent with the federal act and its implementing regulations;

A member of an affiliated group that includes, but is not limited to, persons described in paragraph (a), paragraph (b), paragraph (c), or paragraph (d), which member distributes prescription drugs, whether or not obtaining title to the drugs, only for the manufacturer of the drugs who is also a member of the affiliated group. As used in this paragraph, the term “affiliated group” means an affiliated group as defined in s. 1504 of the Internal Revenue Code of 1986, as amended. The manufacturer must disclose the names of all of its affiliated group members to the department; or

A person permitted as a third party logistics provider, only while providing warehousing, distribution, or other logistics services on behalf of a person described in paragraph (a), paragraph (b), paragraph (c), paragraph (d), or paragraph (e).

What is NOT a “manufacturer”? A Florida-licensed pharmacy operating in compliance with pharmacy practice standards under the Florida Pharmacy Act, Chapter 465, Florida Statutes. Florida law prohibits issuing this permit to an entity holding a Florida pharmacy license, except a nuclear pharmacy license, and then only for purposes of manufacturing prescription drugs used in positron emission tomography or other radiopharmaceuticals.

What activities do NOT require this permit?

  • Pre-Clinical Research & Development: Manufacturing and distributing products that are in an FDA approved investigational program AND that are not manufactured for clinical investigation (for actual use in or on humans or animals).

Domestic Compliance: The applicant must comply with the licensing or permitting requirements of the jurisdiction in which the establishment is located and the federal act. Application must attach copies of all permits or licenses issued to the applicant’s address which authorize the manufacture or possession of prescription drugs at that address, regardless of the issuing agency. If the issuing agency prohibits photocopying the permit or license, the applicant may submit official verification of any permits or licenses issued to the applicant’s address.

FDA-Approval and Imported Prescription Drugs: If a person intends to import prescription drugs from a foreign country into this state, the nonresident prescription drug manufacturer must provide to the department a list identifying each prescription drug it intends to import and document approval by the United States Food and Drug Administration for such importation.

Application: Businesses seeking this permit must complete the Department’s application. Mail or deliver the application and all required attachments to:

Florida Department of Business and Professional Regulation
Division of Drugs, Devices and Cosmetics
2601 Blair Stone Road
Tallahassee, FL 32399-1047

License Term: Nonresident Prescription Drug Manufacturer Virtual permits are valid through the last day of the initial issuance month in the second year of licensure. Example: A permit issued on September 12, 2011 would be valid through September 30, 2013.

Inspection: Passing an onsite inspection is not a prerequisite to issuance of this permit, although the department may conduct a pre-permit or routine inspection of an out-of-state establishment.

Fee: The application and permitting fee is $1,000 for a two-year permit. Make checks payable to DBPR.

Form Assistance

If you have any questions or need assistance completing these forms, please call the Drugs, Devices and Cosmetics Program at (850) 717-1800.

Application Currently Unavailable Using Online Services

Need Help?

All requests for publications, documents, forms, applications for licenses, permits and other similar certifications can be obtained by contacting the Customer Contact Center.

Walter Copeland, Division Director

Division of Drugs, Devices and Cosmetics
2601 Blair Stone Road
Tallahassee, FL 32399-1047

Telephone: 850.717.1800